Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,068 | -255,131 | -1,288 | N/A | N/A |
| Depreciation Amortization | 1,596 | 417 | N/A | N/A | N/A |
| Other Working Capital | 51,717 | -9,522 | 215 | N/A | N/A |
| Other Operating Activity | 6,067 | 227,726 | 50 | 0 | 0 |
| Operating Cash Flow | $-69,688 | $-36,510 | $-1,023 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,040 | -132 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -25,118 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -25,118 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,040 | $-25,250 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 113,174 | 1,900 | N/A | N/A |
| Common Stock Issued | 89,459 | 191,472 | 2 | N/A | N/A |
| Financing Cash Flow | $114,459 | $304,646 | $1,902 | $N/A | $N/A |
| Beginning Cash Position | 243,765 | 879 | N/A | N/A | N/A |
| End Cash Position | 287,496 | 243,765 | 879 | N/A | N/A |
| Net Cash Flow | $43,731 | $242,886 | $879 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,688 | -36,510 | -1,023 | N/A | N/A |
| Capital Expenditure | -1,040 | -132 | 0 | N/A | N/A |
| Free Cash Flow | -70,728 | -36,642 | -1,023 | 0 | 0 |